These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6088102)

  • 1. Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.
    Joss RA; Obrecht JP; Jungi WF; Alberto P; Sauter C; Cavalli F
    Cancer Chemother Pharmacol; 1984; 13(2):148-9. PubMed ID: 6088102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
    Daugaard G; Hansen HH; Rørth M
    Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
    Niederle N; Schütte J; Schmidt CG; Seeber S
    Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
    Bonomi PD; Pazdur R; Stolbach L; Mason B; Ettinger D
    Cancer Treat Rep; 1986 Dec; 70(12):1447-8. PubMed ID: 3024827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
    Niederle N; Schütte J; Krischke W; Seeber S; Schmidt CG
    Klin Wochenschr; 1984 Aug; 62(16):783-6. PubMed ID: 6090762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer.
    Allan SG; Gregor A; Cornbleet MA; Leonard RC; Smyth JF; Grant IW; Crompton GK
    Cancer Chemother Pharmacol; 1984; 13(2):106-8. PubMed ID: 6205780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
    Joss RA; Brunner KW; Goldhirsch A
    Cancer Treat Rep; 1982 Oct; 66(10):1873-4. PubMed ID: 6290051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ; Arnold E; Walter M; Sander U
    Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
    Remick SC; Neville AJ; Willson JK
    Cancer Treat Rep; 1987 Jun; 71(6):575-80. PubMed ID: 3034422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
    Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Chest; 1985 Mar; 87(3):368-72. PubMed ID: 2982552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of vindesine in patients with small cell lung carcinoma.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueda N; Fujii M; Machida K; Ueoka H; Kawahara S; Kozuka A; Kiura K; Moritaka T
    Acta Med Okayama; 1991 Oct; 45(5):357-61. PubMed ID: 1661559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexamethylmelamine (altretamine) in small cell lung cancer (SCLC).
    Comis RL
    Cancer Treat Rev; 1991 Mar; 18 Suppl A():85-90. PubMed ID: 1646071
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
    Drings P; Becker H; Bülzebruck H; Djawid N; Ruchalla E; Stiefel P; Tessen HW
    Onkologie; 1988; 11 Suppl 2():47-56. PubMed ID: 2851761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
    Miller TP; Weick JK; Grozea PN; Carlin DA
    Cancer Treat Rep; 1982 Mar; 66(3):553-6. PubMed ID: 6277487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
    Dhingra HM; Valdivieso M; Carr DT; Chiuten DF; Farha P; Murphy WK; Spitzer G; Umsawasdi T
    J Clin Oncol; 1985 Feb; 3(2):176-83. PubMed ID: 2981982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.